跳至主要内容
临床试验/CTRI/2024/12/077570
CTRI/2024/12/077570尚未招募2 期

CLINICAL EFFICACY OF SARASVATA GHRITA & ITS NASYA IN CHITTODVEGA (GENERALIZED ANXIETY DISORDER)

SUMIT KUMAR1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年12月18日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
SARASVATA GHRITA ORALLY AND ITS NASYA SHOWED CLINICALLY SIGNIFICANT EFFECT IN MANAGING CHITTODVEGA (GENERALIZED ANXIETY DISORDER)

研究概览

简要总结

THIS IS THE OPEN LABEL CLINICAL STUDY  CLINICAL EFFICACY OF SARASVATA GHRITA AND ITS NASYA IN CHITTODVEGA (GENERALISED ANXIETY DISORDER).

This study will be conducted in two group, First group A SARASVATA GHRITA ORALLY in Dose  Of 10 ML Twice a day with luke warm water on Empty Stomach will be Given.

Secound group B NASYA OF SARASVATA GHRITA Instillation of two drop in each Nostril in the morning hours before meals will be given for a period of time 45 days.

Total 40 patient will be registered 20 patient in each group for this study from the OPD/IPD of Quadra institute of ayurveda Roorkee Uttrakhand.will be selected for this study. th patient between the age group of 18-50 years of age .This period of study is 18 month and duration of study 45 days.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • patient willing to participate in the trial and sign the consent form.
  • Individuals between the age group of 18-50 years will be selected.
  • Individual having classical sign and symptom of chittodvega (Generaliosed anxiety disorde).

排除标准

  • Patient not willing for trial.
  • patient below the age 18years and above 50 years will be excluded.
  • 3.Patient suffering from any other concomitant like-thyroid dysfunction, Diabetes mellitus, and heart disease.
  • 4.Patent suffering from any other psychiatric illness.

结局指标

主要结局

SARASVATA GHRITA ORALLY AND ITS NASYA SHOWED CLINICALLY SIGNIFICANT EFFECT IN MANAGING CHITTODVEGA (GENERALIZED ANXIETY DISORDER)

时间窗: FIRST FOLLOW UP - AFTER 15 DAYS OF FIRST TRIAL. | SECOUND FOLLOW UP-15 DAYS AFTER FIRST FOLLOW UP | THIRD FOLLOW UP- 15 DAYS AFTER SECOUND FOLLOW UP

次要结局

  • CLINICAL EFFICACY OF SARASVATA GHRITA & ITS NASYA IN CHITTODVEGA(9GENERALISED ANXIETY DISORDER))

研究者

发起方
SUMIT KUMAR
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Sumit Kumar

Quadra Institute of Ayurveda And Hospital Roorkee

研究点 (1)

Loading locations...

相似试验